Ebers Tech Strategic Cannabinoid Collaboration Update

Cambridge, UK - 9th September 2019

Nuformix, the pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved small molecule drugs is pleased to update shareholders regarding progression within its cannabinoid development collaboration with Ebers Tech Inc. (Ebers).

Download News

Back to all News